Van Lanschot Kempen Investment Management N.V. Acquires Shares of 23,933 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Van Lanschot Kempen Investment Management N.V. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 23,933 shares of the medical equipment provider's stock, valued at approximately $12,492,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new stake in Intuitive Surgical in the 4th quarter valued at $25,000. Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Summit Securities Group LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG traded up $6.46 during midday trading on Friday, hitting $514.59. The company had a trading volume of 2,015,889 shares, compared to its average volume of 1,614,267. The company's 50-day simple moving average is $511.92 and its 200-day simple moving average is $532.42. Intuitive Surgical, Inc. has a 1 year low of $367.39 and a 1 year high of $616.00. The firm has a market capitalization of $183.29 billion, a P/E ratio of 80.28, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the business posted $1.50 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 35,454 shares of company stock valued at $18,564,027 in the last ninety days. Insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on ISRG shares. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Bernstein Bank upped their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday. Finally, Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.